Pfizer and BioNTech approved by DRAP

“We are pleased to announce that Pfizer and BioNTech have received an emergency use authorization from the The Drug Regulatory Authority of Pakistan (DRAP) to supply its COVID-19 vaccine in Pakistan’s immunization program.

We commend the Government of Pakistan for its careful assessment of our COVID-19 vaccine and timely action to help protect the people of the country.

This marks a historic moment further affirming Pfizer’s commitment to the people of Pakistan”. said S. M. Wajeeh, Country Manager Pfizer Pakistan. “We are proud of the fact that a COVAX shipment with Pfizer-BioNTech COVID-19 vaccines have arrived in the country.”

Share:
Posted in Article & Features.

Leave a Reply

Your email address will not be published. Required fields are marked *